{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:49:59Z","timestamp":1758980999183,"version":"3.37.3"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1111\/ced.13315","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T23:53:01Z","timestamp":1512777181000},"page":"354-356","source":"Crossref","is-referenced-by-count":5,"title":["Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7686-1761","authenticated-orcid":false,"given":"J.","family":"Denny","sequence":"first","affiliation":[{"name":"Department of Dermatology; St George's Hospital; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology; St George's Hospital; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Akhras","sequence":"additional","affiliation":[{"name":"Department of Dermatology; St George's Hospital; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"unstructured":"Ingram I FDA Approves anti-PD-1 drug for advanced melanoma http:\/\/www.cancernetwork.com\/news\/fda-approves-pembrolizumab-keytruda-advanced-melanoma","key":"10.1111\/ced.13315-BIB0001|ced13315-cit-0001"},{"key":"10.1111\/ced.13315-BIB0002|ced13315-cit-0002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejca.2016.02.010","article-title":"Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor","volume":"60","author":"Belum","year":"2016","journal-title":"Eur J Cancer"},{"unstructured":"DermNet NZ Lichen planus http:\/\/www.dermnetnz.org\/scaly\/lichen-planus.html","key":"10.1111\/ced.13315-BIB0003|ced13315-cit-0003"},{"key":"10.1111\/ced.13315-BIB0004|ced13315-cit-0004","first-page":"CD001168","article-title":"Interventions for treating oral lichen planus","volume":"7","author":"Thongprasom","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ced.13315-BIB0005|ced13315-cit-0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaad.2015.10.029","article-title":"Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: a single-institution cohort","volume":"74","author":"Hwang","year":"2016","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.13315","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.13315\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:45:41Z","timestamp":1676367941000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/43\/3\/354\/6597225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.13315","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"type":"print","value":"0307-6938"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}